Depo-Provera Cases

If you were diagnosed with a meningioma brain tumor after receiving Depo-Provera injections, you may be entitled to compensation. Thousands of lawsuits have been filed against Pfizer for failing to warn about the increased risk of brain tumors linked to prolonged use of this birth control shot.

What is Depo-Provera?

Depo-Provera is an injectable birth control shot manufactured by Pfizer, containing a synthetic hormone called medroxyprogesterone acetate (MPA). Administered every three months, it has been one of the most widely used contraceptive methods in the United States.

Pfizer Failed to Warn of Increased Risk of Developing Meningiomas

Recent studies have revealed a serious risk that Pfizer failed to disclose for decades: women who use Depo-Provera for more than one year face a significantly increased risk of developing meningiomas — tumors that form in the protective membranes surrounding the brain and spinal cord.

Despite a growing body of evidence suggesting an increased risk of developing meningiomas after using Depo-Provera — and despite the fact that other countries had already added meningioma warnings to the drug’s label — Pfizer did not update the U.S. warning label until the FDA required it to do so in December 2025. By that time, millions of women had used the drug without being informed of the risk.

What Is the Status of the Depo-Provera Lawsuits?

In February 2025, Depo-Provera meningioma lawsuits were consolidated into a federal multidistrict litigation. As of April 2026, more than 3,400 cases are pending in the MDL, with the number growing rapidly each month. The first bellwether trial is scheduled for December 2026.

An MDL is not a class action. An MDL bundles separate lawsuits to save time during pretrial preparation, but each person who has been harmed must file their own individual lawsuit to participate in any recovery.

New cases are still being accepted. If you received Depo-Provera injections and were later diagnosed with meningioma brain tumor, you may be able to participate and recover monetary damages.

Products Covered by This Litigation

• Depo-Provera CI (150 mg intramuscular injection)
• Depo-SubQ Provera 104 (104 mg subcutaneous injection)
• Authorized generic versions of medroxyprogesterone acetate

If you or a loved one developed a meningioma after using Depo-Provera, contact us today for a free case evaluation.